Evidence map›Paper›PMID 37376517›Full record

ArticleVaccines2023

Creating and Activating an Implementation Community to Drive HPV Vaccine Uptake in Texas: The Role of an NCI-Designated Cancer Center.

Rosalind S Bello, Michael T Walsh, Blake Harper, Charles E Amos, Katherine Oestman, Stephanie Nutt, Marcita Galindez, Kaitlyn Block, Ruth Rechis, Erica M Bednar and 5 more

Abstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rosalind S BelloThe HPV Vaccination Initiative, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0009-0005-2405-3558
Michael T WalshThe HPV Vaccination Initiative, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-0666-5340
Blake HarperThe HPV Vaccination Initiative, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Charles E AmosThe HPV Vaccination Initiative, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Katherine OestmanCancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0009-0008-8053-6572
Stephanie NuttCancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Marcita GalindezCancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kaitlyn BlockCancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ruth RechisCancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-9713-3541
Erica M BednarCancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jennifer TektiridisDivision of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Lewis FoxhallOffice of Health Policy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Mark MorenoGovernment Relations, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sanjay SheteDivision of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-7622-376X
Ernest HawkDivision of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-9062-7338

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The University of Texas MD Anderson Cancer Center, a comprehensive cancer center designated by the National Cancer Institute (NCI), defines its service population area as the State of Texas (29.1 M), the second most populous state in the country and the state with the greatest number of uninsured residents in the United States. Consistent with a novel and formal commitment to prevention as part of its core mission, alongside clear opportunities in Texas to drive vaccine uptake, MD Anderson assembled a transdisciplinary team to develop an institutional Framework to increase adolescent HPV vaccination and reduce HPV-related cancer burden. The Framework was developed and activated through a four-phase approach aligned with the NCI Cancer Center Support Grant Community Outreach and Engagement component. MD Anderson identified collaborators through data-driven outreach and constructed a portfolio of collaborative multi-sector initiatives through review processes designed to assess readiness, impact and sustainability. The result is an implementation community of 78 institutions collaboratively implementing 12 initiatives within a shared measurement framework impacting 18 counties. This paper describes a structured and rigorous process to set up the implementation of a multi-year investment in evidence-based strategies to increase HPV vaccination that solves challenges preventing implementation of recommended strategies and to encourage similar initiative replication.

Indexed as

cancer centercancer preventioncommunity of practicedisseminationevidence-based interventionsHPVHPV vaccinationimplementationimplementation networkscalevaccination

Identifiers

PMID37376517
PMCPMC10305309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.